Selumetinib and Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib
Clinical trial NCT01519427 · TERMINATED
Trial details
- NCT number
- NCT01519427
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2013-05-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.